Programme

Please note the programme is still subject to modifications.

 

Thursday, May 09, 2024

Room 1

08:00-09:30 CXR: Basic course from the Golden Age Radiologists
   Moderators: N. Howarth, Chêne-Bougeries/CH; A.R. Larici, Rome/IT

Frontal view, J. Vilar Samper, Valencia/ES
Lateral view, J. Vilar Samper, Valencia/ES
Case-based CXR, T. Franquet, Barcelona/ES

 

09:30-10:00 Break
10:00-10:30 Coffee Break

 

10:30-12:00 Instructional Course on HRCT: Back to basics I
   Moderators: P. Grenier, Saint Cloud/FR; J. Verschakelen, Leuven/BE

The secondary pulmonary lobule: The holy grail of thoracic imaging, H. Prosch, Vienna/AT
The nodular pattern made easy, G. Cicchetti, Rome/IT
The cystic pattern made easy, A. Oikonomou, Toronto/CA

 

12:00-13:00 Industry sponsored lunch symposium
“Photon-counting CT in thoracic imaging: Advancements in ILDs and Pulmonary Hypertension”

This industry symposium will bring together experts, researchers, and practitioners to dive into interstitial lung diseases and the complex perfusion problems addressed through state-of-the-art photon-counting CT technology of NAEOTOM Alpha. Join us to discover the latest breakthroughs, research findings, and practical application of this technology and engage in insightful discussions with our renowned speakers.

Assoc.Prof. Helmut Prosch, MD – Medical University of Vienna
Prof. Hoen-oh Shin, MD – Hannover Medical School

 

13:00-13:30 Break

 

13:30-14:00 Opening Ceremony

A.R. Larici, Rome/IT

 

14:00-15:30 Lung Cancer Screening: An update
   Moderator: C. Schaefer-Prokop, Amersfoort/NL; N. Sverzellati, Parma/IT

What happened in 2023 and what’s on the roadmap for 2024 and 2025?, M-P. Revel, Paris/FR
ESTI paper on definition of positive, indeterminate and negative screen, M. Silva, Parma/IT
Incidental findings: Definition and management, A. Snoeckx, Edegem/BE
AI in the era of lung cancer screening: Where are we now?, C. Jacobs, Nijmegen/NL
Perspectives for lung cancer screening with MRI, J. Biederer, Heidelberg/DE

 

15:30-16:30 Scientific Session 1: LCS
   Moderators: M. Balbi, Turin/IT; A. Snoeckx, Edegem/BE

Patterns of lung cancer risk threshold eligibility influence LDCT outcomes and incidental findings in lung cancer screening – A single centre experience in the NHS Targeted Lung Health Check Programme, TBC
Retrospective validation and comparison of deep learning-based risk thresholds versus growth-based protocols for assessment of persisting pulmonary nodules in screening, N. Antonissen, Nijmegen/NL
Comparison of nodule segmentation algorithms in an LDCT lung cancer baseline screening dataset, Y. Mao, Groningen/NL
Assessing the agreement between privacy-preserving Llama2 model and human experts when labelling radiology reports for specific significant incidental findings in lung cancer screening, F. van der Graaf, Nijmegen/NL
Assessment of incidental findings in lung cancer screening offers potential for improved risk stratification and reduction of total low dose computed tomography burden, A. Faron, Hamburg/DE
Interstitial Lung Abnormalities (ILAs) in Italian Lung Cancer Screening Program: Prevalence and clinical-radiological correlation, C. Giannessi, Firenze/IT
Reconstruction kernels for assessment of lung parenchyma with low dose photon counting computed tomography, G. Bozovic, Lund/SE
Harnessing structured radiology reporting with clinical decision support systems to homogenise reporting in lung cancer screening, TBC
An Italian multicenter pilot study with Low-dose computed tomography for lung cancer screening integrated with smoking cessation: Preliminary baseline results, TBC
The azygos-esophageal recess is not to be missed in screening lung cancer with LDCT, D. Cozzi, Florence/IT

 

16:30-17:00 Coffee Break

 

17:00-18:30 Instructional Course: Pearls and pitfalls in imaging of thoracic emergencies
   Moderators: G. Aviram, Tel Aviv/IL; L. Natale, Rome/IT

Trauma: Non vascular injury, E. Dick, London/UK
Acute Dyspnea: Edema, ARDS and differential Diagnoses, J. Biederer, Heidelberg/DE
Acute chest pain: Non cardiac causes, G. Chassagnon, Paris/FR

Room 2

08:00-09:30 Poster Presentation Session
   Moderator: B.H. Heidinger, Vienna/AT

Introduction, B.H. Heidinger, Vienna/AT
Automated computed tomography airway measures to evaluate response to CFTR therapy in cystic fibrosis, G. Baxter, London/UK
Pilot review of new pathway to expedite CT following abnormal chest radiograph, J. Start, Leeds/UK
Radiation doses and Image Quality in HRCT of the lungs with Photon-Counting-CT (PCCT) expressed as CTDIvol (Computed Tomography Dose Index) or SSDE (Size Specific Dose Estimation) – Does it matter?, G. Bozovic, Lund/SE
Association between visual emphysema on CT and postoperative respiratory complications after esophagectomy, N.Y. Kim, Seoul/KR
Multicentric Magnetic Resonance Imaging of Pulmonary Abnormalities in Children with Primary Ciliary Dyskinesia, L. Wucherpfennig, Heidelberg/DE
Validation and prospective role of low-dose chest CT analysis software with Deep Learning-Based CT Slice Thickness Improvement on a 5mm slice thickness scan, J. Jeong, Seoul/KR
Sarcopenia: An Overlooked predictor of the Progression Risk in Nontuberculous Mycobacterial infections?, B. Gil, Seoul/KR
Development of an assistant system for diagnosis of pulmonary embolism, K.Y. Lee, Guro-gu/KR
Radiomic, clinical, and blood immune-inflammatory features to identify different patterns of acquired resistance in immunotherapy-treated non-small-cell lung cancer patients, C. Marrocchio, Parma/IT
Correlation between Visual Grading and AI-derived Scoring of Coronary Artery Calcification on Non-contrast Chest CT, TBC
A prediction model for pulmonary embolism from clinical and chest X-ray data, C.B. Monti, Milano/IT
Impact of multidisciplinary discussion on patients with interstitial lung disease: A 5-years hub-spoke collaboration, C. Piscitello, Siena/IT
Development and validation of a semiquantitative visual chest CT scoring system for the diagnosis of COVID-19 pneumonia: A multi-reader cross-sectional study, F. Scrocca, Rome/IT
External Validation of Deep Learning-derived Chest Radiographic Age: A Retrospective, Single-center Study, TBC
AI-Assisted Improvement in Detecting Thoracic Abnormalities on Chest Radiographs by Radiologists and Emergency Doctors, TBC

 

09:30-10:00 Industry sponsored slot
10:00-10:30 Coffee Break

 

10:30-12:00 Joint Session: ESTI/Fleischner/KSTR
   Moderators: A. Parkar, Bergen/NO; J.B. Seo, Seoul/KR

The new glossary from the Fleischner Society, D. Kifjak, Vienna/AT
Updates in Lung-RADS, J.M. Goo, Seoul/KR
AI in Chest Radiograph: How to improve our clinical practice, E.J. Hwang, Seoul/KR
Post-acute COVID-19 sequelae, S.H. Yoon/KR
Trends in the incidence of pulmonary nodules in chest CT, C. Schaefer-Prokop, Amersfoort/NL

 

12:00-13:00 Break
13:00-13:30 Industry sponsored slot
13:30-14:00 Break

 

14:00-15:30 Instructional Course on HRCT: Back to basics II
   Moderators: H. Prosch, Vienna/AT; C. Romei, Pisa/IT

Tackling reticular abnormalities, F. Molinari, Tourcoing/FR
Tackling chronic ground glass opacities, W. De Wever, Leuven/BE
The end game: Differential diagnosis of fibrosing lung diseases, L. Calandriello, Rome/IT

 

15:30-16:30 Scientific Session 2: ESTI meets KSTR
   Moderator: C. Marrocchio, Parma/IT

Missed Lung Cancers in Low-dose Chest CT Lung Cancer Screening: Prevalence and Clinicoradiologic Features in South Korea, W.G. Jeong, Hwasun/KR
Evaluation of Short-Term Outcomes in a National Lung Cancer Screening Program in Korea, J.W. Lee, Bucheon/KR
Visual and Artificial Intelligence Analysis of Coronary Artery Calcification in Low-dose Chest CT Lung Cancer Screening in South Korea, W.G. Jeong, Hwasun-gun, Jeollanam-do/KR
Characteristics of ground-glass nodule in female never-smokers with a family history of lung cancer, TBC
Impact of CT Interscan Variability on Coronary Calcium Scores and Cardiovascular Risk Categorization, H. Lee, Hongseong/KR
Incidental Cardiovascular Calcifications Detected on Screening CT: Prognostic Impact over a Ten-year Follow-up, Y-H. Kim, Gwangju/KR
The Performance of artificial intelligence (AI) for the automatic quantification of coronary artery calcium (CAC) on non-contrast chest CT, TBC
Identification of the image quality of chest CT using low-concentration iodine contrast for evaluation of patients with hemoptysis: Comparison of 270 mgl/mL vs. 320 mgl/mL iodine contrast media, TBC
Interobserver Variability in Lung-RADS Categorization of Lung Cancer Screening CT: A Comparison Between a Single Tertiary Hospital and Non-tertiary Hospitals, TBC
Ultrafast scan mode of new-generation wide detector CT scanner for the evaluation of aortic root on non-gated chest CT: Comparison with five different kinds of conventional CT scanner, TBC

 

16:30-17:00 Coffee Break

 

17:00-18:30 Multidisciplinary Session: COPD
   Moderators: P. Grenier, Saint Cloud/FR; M. Occhipinti, Pisa/IT

Interventional treatments for COPD: What pulmonologists need to know?, S. Gasparini, Milan/IT
COPD – The answers from radiologists, J. Verschakelen, Leuven/BE
Imaging of COPD complications, E. Van Beek, Edinburgh/UK

 

 

Friday, May 10, 2024

Room 1

07:30-08:00 ESTI General Assembly

 

08:00-09:30 Technical advances in CT: Just new tools or gamechangers?
   Moderators: Moderators: A. Christe, Bern/CH; M. Prokop, Nijmegen/NL

Photon-counting CT, T. Frauenfelder, Zurich/CH
Upright CT, Y. Ohno, Toyoake/JP
Dual-energy CT, M. Remy-Jardin, Lille/FR
Optimal use of contrast media: How low can we go?, G. Milanese, Parma/IT

 

09:30-10:30 Scientific Session 3: AI & Chest
   Moderators: E. Baratella, Trieste/IT; M‐P. Revel, Paris/FR

Artificial intelligence system for identification of overlooked lung metastasis in abdominal CTs of patients with malignancy, H.S. Cho, Seoul/KR
Performance of AI for preoperative CT assessment of lung metastases: Retrospective analysis of 167 patients, TBC
Towards safe and reliable implementation of AI models for nodule malignancy estimation using distance-based out-of-distribution detection, D. Peeters, Nijmegen/NL
CT deep learning AI model quantified fibrosis predicts survival and treatment response in Pulmonary Hypertension associated with Chronic Pulmonary Obstructive Disease (PH-COPD), TBC
AI based automatic quantitative CT analysis for fissure completeness in Bronchoscopic Lung Volume Reduction: Comparison between CT and ChartisTM, S.M. Lee, Seoul/KR
Artificial intelligence applied to pre-admission chest x-rays: Can we entrust automated readings?, F. Rizzetto, Milan/IT
Exploring the pathological feature extraction ability of a deep learning method on X-ray images using magnetic resonance imaging as ground truth in patients with cystic fibrosis, S. Zhao, Heidelberg/DE
Automatic Classification and Decision Supporting System for Usual Interstitial Pneumonia in Chest Computed Tomography using Convolutional Neural Network, J. Jeong, Seoul/KR
Development of a machine-learning-based CT educational tool for grouping pulmonary hypertension: A proof-of-concept study, L. Cereser, Udine/IT

 

10:30-11:00 Coffee Break

 

11:00-12:00 Instructional Course: Advances in chest intervention
   Moderators: S. Padley, London/UK; C.A. Ridge, London/UK

Advances in interventional maneuvers: From diagnosis …, R. Cazzato, Strasbourg/FR
Advances in interventional maneuvers: … to therapy, R. Iezzi, Rome/IT
Complications: From risk factors to management, T. Frauenfelder, Zurich/CH

 

12:00-12:15 Break

 

12:15-13:15 Industry sponsored lunch symposium
“Thoracic CT in 2024 and beyond: adapting imaging protocols to patients, technology and environmental concerns”
   Moderator: L. Natale, Rome/IT

Patient-centric imaging: how higher iodine concentration may help reduce radiation and contrast exposure, G. Milanese, Parma/IT
Adapting contrast injection protocols to state-of-the-art CT scanner technology, C. Schaefer-Prokop, Nijmegen/NL
Improving environmental sustainability in contrast-enhanced CT: challenges and opportunities, R. Bruno, Milan/IT

 

13:15-13:30 Break

 

13:30-14:45 Will AI make ILD easy?
   Moderators: L. Calandriello, Rome/IT; A. Devaraj, London/UK

Different patterns of ILD, A. Nair, London/UK
Quantification and prognosis, J. Jacob, London/UK
AI application: What did we learn so far?, G. Chassagnon, Paris/FR

 

14:45-15:15 Honorary Lecture & Awarding
   Moderators: J. Biederer, Heidelberg/DE; A.R. Larici, Rome/IT

The role of HRCT in ILD: Evolution from diagnosis to treatment choice, N. Sverzellati, Parma/IT

 

15:15-15:45 Coffee Break

 

15:45-17:15 Multidisciplinary Session on Lung Cancer
   Moderators: T. Blum, Berlin/DE; M-P. Revel, Paris/FR

Introduction, T. Blum, Berlin/DE
The surgeon’s perspective, S. Margaritora, Rome/IT
The oncologist’s perspective, F. Passiglia, Turin/IT
The radiation oncologist’s perspective, S. Ramella, Rome/IT
The radiologist’s perspective, M.A. Sanchez Gonzalez, Barcelona/ES
Panel Discussion: “The role of the tumour board”, All speakers of the session

 

17:15-18:15 Image interpretation quiz (LIVE VOTING)

D. Manos, Halifax/CA; M. Radikė, Liverpool/UK

Room 2

08:00-09:30 Non-thoracic findings on routine chest CT: What to report and what not?
   Moderators: R. Marano, Rome/IT; F. Molinari, Tourcoing/FR

Cardiac, R. Vliegenthart, Groningen/NL
Breast, P. Clauser, Vienna/AT
Bone and muscle, A.P. Parkar, Bergen/NO

 

09:30-10:30 Scientific Session 4: Not only infections
   Moderator: C. De Margerie-Mellon, Paris/FR; B.H. Heidinger, Vienna/AT

Detecting Pulmonary Embolism in Non-Enhanced chest CT: Using Electron Density Maps from Dual-Energy CT, TBC
Thin-section CT findings of miliary tuberculosis and its differential diagnosis from miliary metastasis: Focusing on regional predominance of miliary nodules in terms of their size and profusion, Y.W. Choi, Seoul/KR
Clinical and Serial CT characteristics of COVID-19 pneumonia in Patients with Hematologic Malignancies Showing Persistent SARS-CoV-2 positivity, K. Beck, Seoul/KR
Evaluation of treatment response with serial CT in patients with non-tuberculous mycobacterial pulmonary disease, S. Dettmer, Hannover/DE
Radiologic findings and clinical outcomes of pulmonary nocardiosis; comparison of localized and disseminated, H. Park, Seoul/KR
CT-guided aspiration of pleural empyema and loculated pleural effusion after failed thoracic drainage, TBC
Radiomic features to predict resolved ground glass areas in COVID-19 patients after 12-month follow-up, V. Uggenti, Pisa/IT
Automated quantitative assessment of pulmonary blood volume in COVID-19 pneumonia related-pulmonary embolism: A single-center experience, C. Strappa, Rome/IT
Preliminary results of computed tomography characteristics in smear-negative pulmonary tuberculosis versus non-tuberculous mycobacterium, M.I. Azmi, Cheras/MY
Clinical and imaging features of drug-sensitive and multidrug-resistant tuberculosis: A study of Korean adults, H.S. Cho, Seoul/KR

 

10:30-11:00 Coffee Break

 

11:00-12:00 Radiomics and personalised approach to lung cancer
   Moderator: A. Farchione, Rome/IT

Basic principles and technical evolution, L. Boldrini, Rome/IT
A personalised approach to lung cancer, F. Gleeson, Oxford/UK
Where are we now: Limits and challenges, M. Prokop, Nijmegen/NL

 

12:00-13:00 Break
13:00-13:30 Industry sponsored slot

 

13:30-14:45 Challenging Cases: Interactive session (LIVE VOTING)
Moderator: J. Dinkel, Munich/DE

Challenging ILD cases, C.P. Heussel, Heidelberg/DE
Challenging lung nodule cases, M-P.Revel, Paris/FR
Take home messages, J. Dinkel, Munich/DE

 

15:15-15:45 Coffee Break

 

15:45-17:15 ESTI meets ESCR
   Moderators: J. Bremerich, Basel/CH; R. Vliegenthart, Groningen/NL

Imaging acute aortic syndrome, G. Aviram, Tel Aviv/IL
Imaging post-operative aorta, M. Francone, Rome/IT
Pulmonary hypertension: What role for the radiologist?, N. Screaton, Cambridge/UK
CT in the routine follow-up after heart transplantation, R. Budde, Rotterdam/NL

 

 

Saturday, May 11, 2024

Room 1

08:00-09:00 Granulomatous lung diseases (infectious and noninfectious)
   Moderators: I. Hartmann, Rotterdam/NL; C. Pozzessere, Pully/CH

Tuberculosis: A new look to an old disease, E. Castañer González, Castelldefels/ES
Non tuberculous mycobacteria: A diagnostic challenge, J. Babar, Cambridgeshire/UK
Noninfectious granulomatous lung diseases, M. Both, Kiel/DE

 

09:00-10:00 Scientific Session 5: Chest Oncology
   Moderators: G. Cicchetti, Rome/IT; T. Frauenfelder, Zurich/CH

Large cell carcinoma of the lung: LDCT features and survival in screen-detected immuno-marker undefined cases, TBC
CT patterns and clinical prognosis of radiation pneumonitis in non-small-cell lung cancer patients, H. Kang, Busan/KR
Applicability and accuracy of structured-reporting template in lung cancer staging: A comparative analysis with conventional narrative-reporting, P. Favia, Parma/IT
Enhanced Detection of Malignant Pleural Effusion in Chest CT Scans Using 40 keV Virtual Monoenergetic Images, TBC
MRI-Based Prediction Model for Assessment of Malignancy in Anterior Mediastinal Solid Tumors: Integration of Morphologic, Diffusion, and Perfusion Parameters, Y.J. Jeong, Yangsan/KR
The role of crural diaphragm density in respiratory complications after VATS lobectomy: A retrospective analysis, E. Antognoni, Ferrara/IT
CT-guided transthoracic core needle biopsies of focal pleural lesions smaller than 10 mm: A retrospective study, TBC
Predictive role of radiomic analysis in NSCLC patients treated with immunotherapy in association with ctDNA kinetics, TBC
External Validation of a Convolutional Neural Network Artificial Intelligence Tool to for the Classification of Small (≤2 cm) Pulmonary Nodules on CT Imaging, TBC

 

10:00-10:30 Coffee Break

 

10:30-12:00 ESTI meets SIRM
   Moderator: C. Catalano, Rome/IT; A. Giovagnoni, Ancona/IT

Education of chest radiology in Italy, N. Sverzellati, Parma/IT
LCS in Italy, R.E. Ledda, Parma/IT
Structured reporting in fibrotic ILD, S. Palmucci, Catania/IT
Still room for chest radiograph in pulmonary disease?, E. Baratella, Trieste/IT

 

12:00-13:00 Industry sponsored lunch symposium
13:00-13:30 Break

 

13:30-15:00 9th edition of the TNM classification for thoracic cancers
   Moderators: G. Milanese, Parma/IT; A. Parkar, Bergen/NO

Lung cancer staging: Updates, limitations and perspectives, H. Prosch, Vienna/AT
Staging of pleural mesotheliomas reloaded, I. Hartmann, Rotterdam/NL
Staging of thymic tumors – What is new and what do I need to know, A. Snoeckx, Edegem/BE

 

15:00-16:00 Thoracic Ultrasound
   Moderators: L. Cardinale, Turin/IT; T. Frauenfelder, Zurich/CH

Ultrasound of the lung, M. Radzina, Riga/LV
Ultrasound of the pleura, I. Vollmer Torrubiano, Barcelona/ES
Ultrasound for thoracic intervention, C.P. Heussel, Heidelberg/DE

 

16:00-16:30 Coffee Break

 

16:30-17:30 Imaging after treatment of lung cancer
   Moderators: A. Farchione, Rome/IT; B. Ghaye, Liege/BE

Drug-induced abnormalities in lung cancer patients, C. Schaefer-Prokop, Amersfoort/NL
From wedge to pneumonectomy: Imaging of surgical complications, S. Padley, London/UK
Radiotherapy for lung cancer: Recurrence or treatment effect?, A. Oikonomou, Toronto/CA

 

17:30-18:00 Closing and Awardings

A.R. Larici, Rome/IT; A. Parkar, Bergen/NO

Room 2

08:00-09:00 Is there something new in the ILD?
   Moderator: A. Nair, London/UK; S. Palmucci, Catania/IT

Phenotyping sarcoidosis, N. Sivarasan, London/UK
ILA: Imaging prognostic marker, J.B. Seo, Seoul/KR
Progressive pulmonary fibrosis: A paradigm shift with impact on treatment, A. Devaraj, London/UK

 

09:00-10:00 Scientific Session 6: ILD/Airway diseases/COPD
   Moderators: P‐Y. Brillet, Bobigny/FR; G. Rea, Naples/IT

Interstitial Lung Abnormalities in MRI: Detectability and Quantification Compared to CT as the Gold Standard, TBC
Quantitative evaluation of photon-counting computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor, S. Dettmer, Hannover/DE
Antisynthetase Syndrome-related-ILD: HRCT findings and quantitative analysis in a 5-year monocentric experience, L. Gozzi, Florence/IT
Quantification of the airways’ T2 MRI signal intensity in Asthma, I. Benlala, Pessac/FR
Quantitative HRCT assessment during nintedanib treatment in systemic sclerosis interstitial lung disease and idiopathic pulmonary fibrosis, V. Uggenti, Pisa/IT
CT features of interstitial lung disease associated with systemic lupus erythematosus, A. Sajust de Bergues de Escalup, Paris/FR
Estimating Respiratory Mortality in Chronic Obstructive Pulmonary Disease: Open-Source AI-based Risk Assessment Using Chest Radiographs, H. Kim, Seoul/KR
Prevalence and progression of interstitial lung abnormalities: A systematic review and meta-analysis, S. You, Suwon/KR
Quantitative CT Associate Airway Variant with Regional Lung Structure-Function Impairment in Recovery from Humidifier Disinfectant-associated Lung Injury, TBC

 

10:00-10:30 Coffee Break

 

10:30-12:00 Airway disease: From basics to advanced imaging
   Moderators: J. Babar, Cambridgeshire/UK; F. Gleeson, Oxford/UK

Imaging of the trachea and proximal airways, P-Y. Brillet, Bobigny/FR
Imaging bronchiectasis: What’s new, M. Prokop, Nijmegen/NL
Qualitative and quantitative CT assessment of COPD, M. Occhipinti, Pisa/IT
MRI for the assessment of patients with COPD, J. Biederer, Heidelberg/DE

 

12:00-13:00 Break

13:00-13:30 ILA: What’s new?
   Moderators: A.R. Larici, Rome/IT; L. Richeldi, Rome/IT

Pitfalls in nodule management, A. Kerpel-Fronius, Budapest/HU
Lung cancer staging – Tips and tricks, M. Silva, Parma/IT
Interstitial lung diseases – Not what it seems, C. Ridge, London/UK

 

13:30-15:00 Not only Infections
   Moderators: E. Castañer González, Castelldefels/ES; R. Polverosi, Padua/IT

Infectious diseases in immunocompromised patients, T. Franquet, Barcelona/ES
CAP – Community acquired pneumonias, C. De Margerie-Mellon, Paris/FR
The many faces of pulmonary aspiration, T. Franquet, Barcelona/ES

 

15:00-16:00 Instructional Course: Pitfalls in thoracic imaging (LIVE VOTING)
Moderator: C. Schaefer-Prokop, Amersfoort/NL

Pitfalls in nodule management, A. Kerpel-Fronius, Budapest/HU
Lung cancer staging – Tips and tricks, M. Silva, Parma/IT
Interstitial lung diseases – Not what it seems, C.A. Ridge, London/UK

 

16:00-16:30 Coffee Break

 

16:30-17:30 Multidisciplinary Session on ILD
   Moderators: N. Sverzellati, Parma/IT; C. Vancheri, Catania/IT

Treatment of ILD in a nutshell, L. Richeldi, Rome/IT
New diagnostic biomarkers for UIP, A. Unterman, Tel Aviv/IL
Acute Lung Injury and the development of the NSIP and UIP patterns of fibrosis, S. Kligerman, Denver/US

X